Ketorolac Tromethamine Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Mar 23, 2018. Reported reason: Delay in shipping of the drug

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-162-02
Dosage Form
Injection
Presentation
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)
Initial Posting
Mar 23, 2018

Reason

Delay in shipping of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.